跳至主要内容
临床试验/ACTRN12621000734864
ACTRN12621000734864招募中未知

The TOP UP Trial - Examining the effect of a physiotherapy-led telehealth and exercise intervention on mobility in older people receiving aged care services: an effectiveness and implementation randomised controlled trial.

Concord Repatriation General Hospital0 个研究点目标入组 240 人开始时间: 2021年6月10日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 o limit(—)
性别
All

入选标准

  • Eligible participants will:
  • a) Age: 65 + years
  • b) Living in the community or in residential aged care facilities receiving Commonwealth funded aged care services
  • c) Able to walk 10 m +/- walking aid
  • d) Have internet connectivity to access mobile device/tablet
  • e) Life expectancy > 6 months and sufficient sensory, neurological , cognitive, and English language skills for exercise and video-based interventions
  • f) Participants will need to be assessed by their aged care provider as having normal or mild cognitive impairment by one of the following cognitive assessments: attain a score of 18 or more on the Mini State Mental Examination (MMSE), or 20 or more on the Rowland Universal Dementia Assessment Scale (RUDAS), or 10 or less on the Psychogeriatric Assessment Scales Cognitive Impairment Scale (PAS-Cog) or 4 or more on the Memory Impairment Scale (MIS)
  • g) Obtain participant consent or from their person responsible if the participant has mild cognitive impairment

排除标准

  • The trial will exclude adults who:
  • a) are expected to live for less than 6 months
  • b) Having participated in a similar physiotherapy program in the last 12 months
  • c) Having physical, sensory, mental health or behavioural issues that would prevent participation in the intervention as identified by our aged care partners
  • d) People who are unable to cooperate with an intervention program. Cognitive impairment per se is not an exclusion criterion but older people with moderately severe dementia assessed by a score of 17 or less on the MMSE, a score of 19 or less on the RUDAS, a score more than 10 on the PAS-Cog, or a score of 20 or less on the Modified Telephone Interview Cognitive Status may not be able to participate.

研究者

相似试验

尚未招募
不适用
The Trigger of the First Trial Effect: examing pure Sensory Polyneuropathy PatientsSensory Polyneuropathysensory loss in the feet and lower legs1001265310034606
NL-OMON36041niversitair Medisch Centrum Sint Radboud30
尚未招募
不适用
A scientific trail to evaluate the effect of a 13 week long lifestyle change program, anchored in the science of yoga i.e Swasth Wellness Program (SWP), on the systolic blood pressure, in subjects who are not on any anti-hypertensive treatment.
CTRI/2021/03/031779Mr Sundeep Kapalia
进行中(未招募)
不适用
IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome(Dose Escalation Study: Varespladib Infusion [A-001] for the Prevention of Acute Chest Syndrome in At-Risk Patients with Sickle Cell Disease and Vaso-occlusive Crisis) - IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest SyndromeAcute Chest Syndrome (ACS) in At-Risk patients with Sickle Cell Disease (SCD) and Vaso-occlusive Crisis (VOC)MedDRA version: 9.1Level: LLTClassification code 10051895Term: Acute chest syndrome
EUCTR2007-000969-37-FRAnthera Pharmaceuticals Incorporated75
进行中(未招募)
不适用
IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome(Dose Escalation Study: Varespladib Infusion [A-001] for the Prevention of Acute Chest Syndrome in At-Risk Patients with Sickle Cell Disease and Vaso-occlusive Crisis) - IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome
EUCTR2007-000969-37-GBAnthera Pharmaceuticals Incorporated75
已完成
不适用
A Preliminary Trial of the Introduction of Computerised Decision Support to Assist Resuscitation of the Severely Injured in a Level 1 Trauma Centre in IndiaInjuries
ACTRN12618001053213Monash University100